Internal Medicine Alert - June 30, 2011

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Allan J. Wilke, MD, MA,
Chair, Department of Integrative Medicine
Ross University School of Medicine
Commonwealth of Dominica

Barbara A. Phillips, MD, MSPH
Professor of Medicine,
University of Kentucky;
Director, Sleep Disorders Center
Samaritan Hospital, Lexington

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine,
UCLA School of Medicine

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • I Can't Get No Salivation
  • Desperate Diseases Call for Drastic Diets
  • Proton Pump Inhibitors and Clopidogrel
  • Telaprevir Film-Coated Tablets (Incivekā„¢)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Amylin, Boehringer
Ingelheim, Novo Nordisk, and Symbiotix; he serves on the speakers bureau of Boehringer Ingelheim, Novo
Nordisk, and Teva. Associate editors Allan J. Wilke, MD, MA, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Associate editor Barbara A. Phillips, MD, MSPH serves on the speakers bureaus for Cephalon, Resmed, and Respironics. Associate editor Harold L. Karpman, MD, FACC, FACP serves on the speakers bureau for Forest Laboratories.

Copyright 2011 AHC Media LLC. All rights reserved.